LLY

Eli Lilly and Company

$1,426.91+$15.92+1.13%Price as of Nov 3, 2026, 9:34 AM ET

Key stats

Market cap: 1.27T
Open: —
Day range: —
52-week range: $850.51 – $1,449.68
Volume: 116K
Avg volume: 2.59M

Earnings

Q3 FY26Beat

Expected$6.32

Actual$7.48

Q2 FY26

Actual$7.94

Q1 FY26

Actual$8.26

Q4 FY25

Actual$7.39

About

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.

Employees: 50,000
Headquarters: Indianapolis, IN